Parivartan Pharma And Cosmetics India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-12-2024
- Paid Up Capital ₹ 0.10 M
as on 18-12-2024
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.40 M
as on 18-12-2024
- Revenue %
(FY 2022)
- Profit -14.36%
(FY 2022)
- Ebitda -10.12%
(FY 2022)
- Net Worth -6.89%
(FY 2022)
- Total Assets -24.31%
(FY 2022)
About Parivartan Pharma And Cosmetics India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.40 M.
Baburao Lokhande and Krushna Vitthalrao serve as directors at the Company.
- CIN/LLPIN
U85191MH2012PTC234423
- Company No.
234423
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Aug 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Parivartan Pharma And Cosmetics India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Baburao Lokhande  | Director Appointed In Casual Vacancy | 06-Apr-2015 | Current |
| Krushna Vitthalrao | Additional Director | 10-Jun-2019 | Current |
Financial Performance of Parivartan Pharma And Cosmetics India.
Parivartan Pharma And Cosmetics India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 14.36% decrease in profit. The company's net worth dipped by a decrease of 6.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parivartan Pharma And Cosmetics India?
In 2019, Parivartan Pharma And Cosmetics India had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ayurkanti Private LimitedActive 8 years 4 monthsBaburao Lokhande and Krushna Vitthalrao are mutual person
- Parivartan Foods And Beverages Private LimitedActive 12 years 6 months
Baburao Lokhande and Krushna Vitthalrao are mutual person
- Parivartan Agro & Real Estate (India) Private LimitedActive 15 years 9 months
Baburao Lokhande is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Jul 2016 | ₹3.40 M | Open |
How Many Employees Work at Parivartan Pharma And Cosmetics India?
Unlock and access historical data on people associated with Parivartan Pharma And Cosmetics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parivartan Pharma And Cosmetics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parivartan Pharma And Cosmetics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
